1.00
price up icon5.26%   0.05
after-market Dopo l'orario di chiusura: 1.00
loading
Precedente Chiudi:
$0.95
Aprire:
$0.931
Volume 24 ore:
11,374
Relative Volume:
0.23
Capitalizzazione di mercato:
$38.04M
Reddito:
$13.42M
Utile/perdita netta:
$-73.35M
Rapporto P/E:
-0.5208
EPS:
-1.92
Flusso di cassa netto:
$-56.34M
1 W Prestazione:
-7.41%
1M Prestazione:
-9.09%
6M Prestazione:
-33.33%
1 anno Prestazione:
-63.15%
Intervallo 1D:
Value
$0.931
$1.00
Intervallo di 1 settimana:
Value
$0.92
$1.1088
Portata 52W:
Value
$0.8008
$4.1591

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile

Name
Nome
Barinthus Biotherapeutics Plc Adr
Name
Telefono
44 (0) 1865 818808
Name
Indirizzo
UNIT 6-10, ZEUS BUILDING, DIDCOT
Name
Dipendente
130
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
BRNS's Discussions on Twitter

Confronta BRNS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BRNS
Barinthus Biotherapeutics Plc Adr
1.00 38.04M 13.42M -73.35M -56.34M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-05-25 Iniziato Jefferies Buy
2021-05-25 Iniziato Morgan Stanley Overweight
2021-05-25 Iniziato William Blair Outperform
2021-05-24 Iniziato H.C. Wainwright Buy

Barinthus Biotherapeutics Plc Adr Borsa (BRNS) Ultime notizie

pulisher
Jan 10, 2025

Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com

Jan 10, 2025
pulisher
Nov 15, 2024

New trial shows promise for chronic hepatitis B treatment - Investing.com India

Nov 15, 2024
pulisher
Oct 01, 2024

Barinthus Bio completes enrollment for two clinical trials - Investing.com India

Oct 01, 2024
pulisher
Sep 25, 2024

Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer

Sep 25, 2024
pulisher
Sep 24, 2024

Barinthus Bio launches Phase 1 celiac disease therapy trial - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Barinthus Biotherapeutics Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease - Investing.com

Sep 24, 2024
pulisher
Sep 05, 2024

Barinthus Biotherapeutics appoints new COO - Investing.com

Sep 05, 2024
pulisher
Sep 05, 2024

BRNS Stock Touches 52-Week Low at $1.14 Amid Market Challenges - Investing.com UK

Sep 05, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 21, 2024
pulisher
May 01, 2024

Kintara Therapeutics restructures share designations By Investing.com - Investing.com

May 01, 2024
pulisher
Mar 18, 2024

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 18, 2024
pulisher
Mar 13, 2024

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance

Mar 13, 2024
pulisher
Apr 30, 2021

Vaccitech (VACC) Stock Price, News & Analysis - MarketBeat

Apr 30, 2021
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011

Barinthus Biotherapeutics Plc Adr Azioni (BRNS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Capitalizzazione:     |  Volume (24 ore):